Recursion Pharmaceuticals Inc Clas (RXRX)

Operating Cash Flow Growth

8.50%

TTM · Period ending:

RXRX logo

RXRX Operating Cash Flow Growth

Year-over-year change vs the same period a year earlier

Latest reported8.50%
RXRX TTM Cash from Operations YoY % (-249.38% → 8.50%)
High-resolution chart · PNG

RXRX operating cash flow growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Recursion Pharmaceuticals Inc Clas Operating Cash Flow Growth — Trailing twelve months (TTM)
Period endingOperating Cash Flow Growth
8.4978%
17.4572%
-3.5175%
-38.8093%
-15.5389%
-22.751%
-24.8085%
-22.9715%
-38.0902%
-35.2375%
-244.5477%
-158.6217%
-206.0542%
-364.0843%
47.3413%
-12.4332%
-4.1838%
13.4837%
-249.3777%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.